Literature DB >> 28355422

How We Evaluate Biomarker Studies.

Mintu P Turakhia, Marc S Sabatine.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28355422     DOI： 10.1001/jamacardio.2017.0291

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  3 in total

1.  A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer.

Authors:  Nguyen Phuoc Long; Sang Jun Yoon; Nguyen Hoang Anh; Tran Diem Nghi; Dong Kyu Lim; Yu Jin Hong; Soon-Sun Hong; Sung Won Kwon
Journal:  Metabolomics       Date:  2018-08-10       Impact factor: 4.290

2.  Integration of metabolites from meta-analysis with transcriptome reveals enhanced SPHK1 in PDAC with a background of pancreatitis.

Authors:  Vijayasarathy Ketavarapu; Vishnubhotla Ravikanth; Mitnala Sasikala; G V Rao; Ch Venkataramana Devi; Prabhakar Sripadi; Murali Satyanarayana Bethu; Ramars Amanchy; H V V Murthy; Stephen J Pandol; D Nageshwar Reddy
Journal:  BMC Cancer       Date:  2022-07-19       Impact factor: 4.638

3.  OXY-SCORE: a new perspective for left ventricular hypertrophy diagnosis.

Authors:  Begoña Quintana-Villamandos; Laia Pazó-Sayós; Irene González Del Pozo; Pilar Rodríguez-Rodríguez; Jose María Bellón; Álvaro Pedraz-Prieto; Ángel G Pinto; Maria Carmen González
Journal:  Ther Adv Chronic Dis       Date:  2020-06-27       Impact factor: 5.091
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.